Literature DB >> 30478722

Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.

Roberto Castelli1, Paolo Gallipoli2, Riccardo Schiavon3, Thomas Teatini3, Giorgio Lambertenghi Deliliers4, Luigi Bergamaschini3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30478722     DOI： 10.1007/s11239-018-1773-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  3 in total

1.  Genetic factors affecting thrombosis in patients with essential thrombocythemia by heparin treatment.

Authors:  Tomoyuki Kawada
Journal:  J Thromb Thrombolysis       Date:  2019-10       Impact factor: 2.300

2.  Surgical Complications in Myeloproliferative Neoplasm Patient with Essential Thrombocythemia: A Case Report.

Authors:  Ikhwan Rinaldi; Abdul Muthalib; Teguh Wijayadi; Barlian Sutedja; Nelly Susanto; Lingga Magdalena; Jeremy Rafael Tandaju; Indy Larasati Wardhana; Kevin Winston
Journal:  Int Med Case Rep J       Date:  2022-09-12

3.  What cardiologists should know about essential thrombocythemia and acute myocardial infarction: report of two cases and advanced heart failure therapies considerations.

Authors:  Marie-Camille Soucy-Giguère; Pierre Yves Turgeon; Mario Sénéchal
Journal:  Int Med Case Rep J       Date:  2019-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.